Epidemic of COVID-Associated Mucormycosis in India and a road ahead
COVID-associated Mucormycosis (CAM) was a peak-hour crisis in India. The situation arose from an unprecedented ICU workload of critical COVID-19 cases, insufficient resources and the impaired immune status of the patient. We recommend strong preventive measures, chemoprophylaxis and Amphotericin-B n...
Saved in:
Main Authors: | S. Sharma (Author), P. Sharma (Author), U. K. Chandra (Author), S. Javed (Author), A. Nambiar (Author), V. K. Sharma (Author) |
---|---|
Format: | Book |
Published: |
Sri Lanka College of Internal Medicine,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The road ahead
by: Srinivas Gosla Reddy
Published: (2018) -
COVID-19-associated rhino-mucormycosis and pulmonary aspergillosis infection
by: Jitender Singh, et al.
Published: (2022) -
Sirtuins & disease: the road ahead
by: Vincenzo eCarafa, et al.
Published: (2012) -
Risk factors for severe rhino-orbital mucormycosis during its epidemic post-COVID-19 pandemic
by: Gopal Krushna Das, et al.
Published: (2022) -
Digitalisation For Sustainable Infrastructure: The Road Ahead
by: Secchi, Carlo
Published: (2022)